- Home
- CMND vs IMCC Comparison
CMND vs IMCC Comparison
Compare CMND & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMND
- IMCC
- Stock Information
- Founded
- CMND 2017
- IMCC 1980
- Country
- CMND Canada
- IMCC Israel
- Employees
- CMND N/A
- IMCC N/A
- Industry
- CMND Biotechnology: Pharmaceutical Preparations
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- CMND Health Care
- IMCC Health Care
- Exchange
- CMND Nasdaq
- IMCC Nasdaq
- Market Cap
- CMND 6.0M
- IMCC 7.5M
- IPO Year
- CMND N/A
- IMCC N/A
- Fundamental
- Price
- CMND $1.13
- IMCC $1.82
- Analyst Decision
- CMND
- IMCC
- Analyst Count
- CMND 0
- IMCC 0
- Target Price
- CMND N/A
- IMCC N/A
- AVG Volume (30 Days)
- CMND 56.1K
- IMCC 6.6K
- Earning Date
- CMND 04-15-2025
- IMCC 05-07-2025
- Dividend Yield
- CMND N/A
- IMCC N/A
- EPS Growth
- CMND N/A
- IMCC N/A
- EPS
- CMND N/A
- IMCC N/A
- Revenue
- CMND N/A
- IMCC $38,042,859.00
- Revenue This Year
- CMND N/A
- IMCC $22.59
- Revenue Next Year
- CMND N/A
- IMCC $32.86
- P/E Ratio
- CMND N/A
- IMCC N/A
- Revenue Growth
- CMND N/A
- IMCC N/A
- 52 Week Low
- CMND $0.95
- IMCC $1.61
- 52 Week High
- CMND $2.30
- IMCC $8.10
- Technical
- Relative Strength Index (RSI)
- CMND 39.96
- IMCC 37.50
- Support Level
- CMND $1.05
- IMCC $1.82
- Resistance Level
- CMND $1.16
- IMCC $2.15
- Average True Range (ATR)
- CMND 0.06
- IMCC 0.12
- MACD
- CMND -0.00
- IMCC -0.02
- Stochastic Oscillator
- CMND 27.30
- IMCC 14.89
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.